Canada Markets closed

Global Non-Hodgkin Lymphoma Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Market Forecast, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

·2 min read

DUBLIN, December 01, 2021--(BUSINESS WIRE)--The "Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021, provides comprehensive insights into Non-Hodgkin Lymphoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.

This research analyzes and forecasts Non-Hodgkin Lymphoma market size and drug sales. It also provides insights into Non-Hodgkin Lymphoma epidemiology and late-stage pipeline.

This research covers the following - Non-Hodgkin Lymphoma treatment options, Non-Hodgkin Lymphoma late-stage clinical trials pipeline, Non-Hodgkin Lymphoma prevalence by countries, Non-Hodgkin Lymphoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global

  • Non-Hodgkin Lymphoma pipeline: Find out drugs in clinical trials for the treatment of Non-Hodgkin Lymphoma by development phase 3, phase 2, by pharmacological class and company

  • Non-Hodgkin Lymphoma epidemiology: Find out the number of patients diagnosed (prevalence) with Non-Hodgkin Lymphoma by countries

  • Non-Hodgkin Lymphoma drugs: Identify key drugs marketed and prescribed for Non-Hodgkin Lymphoma in the US, including trade name, molecule name, and company

  • Non-Hodgkin Lymphoma drugs sales: Find out the sales value for Non-Hodgkin Lymphoma drugs by countries

  • Non-Hodgkin Lymphoma market valuations: Find out the market size for Non-Hodgkin Lymphoma drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Non-Hodgkin Lymphoma drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Non-Hodgkin Lymphoma drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Non-Hodgkin Lymphoma market

  • Develop in-depth knowledge of competition and markets

  • Analyze Non-Hodgkin Lymphoma drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Non-Hodgkin Lymphoma market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/r/gek5cz

View source version on businesswire.com: https://www.businesswire.com/news/home/20211201005765/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest Stories

  • Credit Suisse hikes cash bonuses as talent war rages

    ZURICH (Reuters) -Credit Suisse is boosting cash payouts for senior bankers, it told employees on Friday, as it tries to retain top performers after a year of scandals saw its shares lose more than a quarter of their value. The bank, which has been hit by a string of scandals and losses, is increasing the cash portion of short term bonuses senior staff receive and reducing the amount they get in shares that vest after one year, according to a memo seen by Reuters. On Thursday, Deutsche Bank said compensation at its investment bank rose 30% in the fourth quarter of last year.

  • 2022 Best New Product Awards reveals health, well-being, and better-for-you-foods are top of mind with Canadians

    Today, the results of the 19th annual Best New Product Awards (BNPA) were released together with new research by BrandSpark International on Canadians' shopping habits for consumer products. More than 12,000 Canadians voted on the latest beauty, health, personal care, food, beverage, household, home goods and pet products in 77 categories.

  • Health Canada Authorizes Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for patients with HR+ HER2- High Risk Early Breast Cancer

    Lilly Canada is pleased to announce that Health Canada has authorized Verzenio® (abemaciclib) (tablets), in combination with endocrine therapy, for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of disease recurrence based on clinicopathological features and a Ki-67 score ≥20%. Ki-67 is a marker of cellular proliferation. Verzenio is the first and only CDK4/6 i

  • Nova Scotia Power's proposed fee for solar homeowners draws pushback from installers

    HALIFAX — A Nova Scotia Power proposal to charge fees for customers who sell power back to the grid has drawn heated criticism from solar installers who say it will damage the emerging industry. The utility applied Thursday before the Utility and Review Board for a monthly fee of about $8 per kilowatt of electricity, which in a typical 10-kilowatt photovoltaic solar installation would amount to about $960 annually. David Brushett, the chairman of Solar Nova Scotia, says this would be a massive r

  • Largo (TSX:LGO) Stock Is Down 16% in 2022: Should You Buy the Dip?

    Largo Inc. (TSX:LGO) is a Canadian stock that has had a rough start to 2022, but it is worth snatching up on the dip. The post Largo (TSX:LGO) Stock Is Down 16% in 2022: Should You Buy the Dip? appeared first on The Motley Fool Canada.

  • Tenet Unveils New Brand Identity

    Tenet Fintech Group Inc. (CSE: PKK) (OTC PINK: PKKFF) ("Tenet" or the "Company"), an innovative Fintech and AI service provider and manager of the Business Hub™, unveiled its new brand identity today. Tenet has completed an extensive rebranding effort in response to accelerated company growth and a renewal to its corporate vision.

  • TFSA Retirees: This ETF Will Help You Generate $3,100 in Tax-Free Income Each Year

    Vanguard FTSE Canadian High Dividend Yield Index ETF is an ideal investment for income-seeking retirees. The post TFSA Retirees: This ETF Will Help You Generate $3,100 in Tax-Free Income Each Year appeared first on The Motley Fool Canada.

  • Stories from Canadian Muslims reveal Islamophobia is systemic and normalized

    In time for the fifth anniversary of the Quebec mosque shooting anniversary and the National Day of Action Against Islamophobia, Islamic Relief Canada is releasing a new report today that sheds light on how everyday Islamophobia affects Canadian Muslims.

  • AT&T Mexico says govt should limit America Movil's market concentration - paper

    AT&T's top executive in Mexico has urged the government to place limits on its telecom rival America Movil and keep it out of new markets to ensure fair competition, Mexican newspaper Reforma reported on Friday. The warning by Monica Aspe, chief executive of AT&T Mexico, comes days after Mexican regulators withheld a pay TV permit from America Movil amid complaints from rivals the move would further enhance its dominance. Aspe said Mexican regulators needed to maintain an even playing field to keep companies such as AT&T in the country.

  • NexGen Reports 2021 Exploration and Site Geotechnical Confirmation Drilling Results

    NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce radioactivity results and the completion of the 2021 field programs that focused on exploration and a detailed geotechnical site confirmation program at the Arrow Deposit ("Arrow" or the "Project") at the 100% owned, Rook I property, in the Athabasca Basin, Saskatchewan.

  • ECB kicks off climate stress test for banks

    The European Central Bank launched a stress test on Thursday to assess how prepared banks are to deal with potential shocks stemming from climate risk, it said in a statement. The ECB has long warned that euro zone lenders are failing to meet its climate risk management goals, and repeatedly called on them to adjust to its standards more quickly. "This is not a pass or fail exercise, nor does it have direct implications for banks’ capital levels," the ECB said.

  • Is Ripple Primed for 100% Growth in 2022?

    Ripple’s downfall from the last 12-month peak has been almost as harsh as Bitcoin’s, but its recovery might also be more pronounced. The post Is Ripple Primed for 100% Growth in 2022? appeared first on The Motley Fool Canada.

  • Hong Kong economy grows 6.4% in 2021

    BEIJING (AP) — Hong Kong’s economy grew by 6.4% last year after activity weakened as anti-coronavirus controls were tightened. Economic output expanded by 4.8% over a year earlier in the three months ending in December, down from the previous quarter’s 5.5%, government data showed Friday. Growth in consumption and investment weakened. The government has tightened controls on travel into Hong Kong and activity within the territory, mimicking the Chinese mainland’s “zero tolerance” strategy that a

  • Trudeau should 'hold the line' on vaccine trucker mandate

    On Jan. 15, Prime Minister Justin Trudeau’s federal government implemented a vaccine mandate that will require unvaccinated Canadian truck drivers undergo testing and quarantine upon entry into Canada. Unvaccinated Canadian truck drivers are also not permitted to enter the United States. The U.S. implemented its own policy on Jan. 22, barring all unvaccinated individuals travelling for essential or non-essential purposes from entering the country. Industry groups had warned the government that a vaccine requirement for truck drivers would create added pressure on an already-strained supply chain system. Backlash to the policy has emerged this week, as truckers and protesters from across the country head to Ottawa for a rally against the vaccine mandate. On this episode of Editor's Edition, Alicja Siekierska and the Public Policy Forum's Sean Speer dig into the trucker vaccine mandate policy, whether the Trudeau government should have moved forward with the policy, and the backlash that has emerged. Speer says that while Trudeau has made mistakes in how he has spoken about the unvaccinated, he argues that the government needs to ‘hold the line’ on the policy. “At its core, the government’s position on these issues is right,” Speer said.

  • Fiery Georgia crash that killed 6 women leads to lawsuits

    KENNESAW, Ga. (AP) — Family members of women in a sober living group home who were killed and injured in a fiery van crash last year are suing a car company and the group home, saying the 2002 Dodge Ram was prone to tipping over and was not properly maintained. Just before the April crash, a vehicle ahead of the passenger van unexpectedly changed lanes on a Georgia interstate, police said at the time. The van then went out of control, rolled onto its side and slid across two lanes, bursting into

  • VIZSLA PROVIDES 2021 YEAR-END SUMMARY AND 2022 OUTLOOK

    Vizsla Silver Corp. (TSXV: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla" or the "Company") is pleased to provide a year-end summary of its activities at its flagship Panuco silver-gold property (the "Property" or "Panuco") located in Sinaloa, Mexico and outline the Company's key objectives/milestones for 2022.

  • Musk's bets on Tesla: human-like robots and self-driving cars

    (Reuters) -Tesla's most important products this year and next will not be cars, Chief Executive Elon Musk said on Wednesday, but software that drives them autonomously and a humanoid robot. Tesla and other auto technology companies have missed their targets to deploy self-driving cars for years. Musk has built a career on defying skeptics with businesses in electric cars and rockets.

  • Revision and Significant Increase to Previously Announced Assay Results for Holes HVD006 and HVD007 at Happy Valley

    E79 Resources Corp. (CSE: ESNR) (OTCQB: ESVNF) ("E79" or the "Company") announces that results previously reported for two drillholes, HVD006 and HVD007 (see Company's press release dated November 15, 2021), have been significantly upgraded after identification of a laboratory issue with the initial fire assays noticed via internal QAQC procedures. Both holes were drilled at the Happy Valley prospect on the Myrtleford Exploration License (EL) in the Victorian Goldfields, Australia.

  • Analysis-Robinhood shares stumble as trading frenzy wanes, regulators circle

    Robinhood Markets Inc became a household name ahead of its stellar IPO last year, when retail investors used its trading app to drive shares of GameStop and other "meme stocks" into the stratosphere, but name recognition has not helped its share price lately. “The market is not being very patient with them,” said Greg Martin, co-founder and managing director at Rainmaker Securities, a brokerage specializing in private company deals. Waning investor interest in retail trading has weighed on shares of the commission-free online brokerage, which saw explosive growth at the beginning of 2021 as retail investors gobbled up viral stocks https://www.reuters.com/article/us-retail-trading-robinhood-anger/robinhood-is-new-eye-of-gamestop-storm-as-outrage-grows-idUSKBN29X33D including GameStop and AMC Entertainment.

  • Northrop sales disappoint as supply chain snarls restrict deliveries

    (Reuters) -Northrop Grumman Corp missed fourth-quarter revenue estimates on Thursday as labor shortages and supply chain snarls hampered its ability to deliver components for defense products, including Lockheed Martin's F-35 jets. The drop was driven by a 25% decline in revenue from its aeronautics unit that makes the center fuselage for fighter jets and also reflected how the pandemic has hobbled manufacturers by disrupting supply chains. Northrop's shares fell 1.7% before the bell as its 2022 forecast suggested the supply chain pressure was likely to continue.